$ 467.06
Key Takeaways
Risk factor
Negligible price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
In Guru Portfolios
About
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI
Data is available to registered users only
Target Price
The average target price of AMGN is 425 and suggests 9.21% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Data is available to registered users only